Share
CNBC Pro

Watch CNBC's full interview with Gilead CEO Daniel O’Day

CNBC's Meg Tirrell sits down with Gilead CEO Daniel O’Day amid the American Society of Clinical Oncology conference in Chicago to discuss the company's latest data surrounding its cancer drug Trodelvy. "We think this data is very important for patients," O’Day tells CNBC. "We'll be moving forward to have discussions with the FDA."
05:47
Mon, Jun 6 20228:34 AM EDT

watch now
VIDEO06:13
CNBC ProWatch CNBC's full interview with Evercore ISI's Mark Mahaney
watch now
VIDEO10:24
CNBC ProWatch CNBC's full interview with Eli Lilly CEO David Ricks on earnings
watch now
VIDEO05:51
CNBC ProWatch CNBC's full interview with Booking Holdings CEO Glenn Fogel
watch now
VIDEO02:35
CNBC ProMarkets are poised for a powerful end-of-year rally, says investor
watch now
VIDEO45:13
CNBC ProWatch Wednesday's full episode of Mad Money with Jim Cramer — August 3, 2022